Sundry Photography/iStock Editorial via Getty Images
Abbott Laboratories (NYSE:ABT) added ~5% to record its best intraday gain in nearly two years on Wednesday after the company reaffirmed its full-year outlook while estimating “a few hundred million dollars” of impact related to tariffs.
Earlier in the day, the